TY - JOUR AU - Valencia, O. M. AU - Samuel, S. E. AU - Viscusi, R. K. AU - Riall, T. S. AU - Neumayer, L. A. AU - Aziz, H. PY - 2017 DA - 2017// TI - The role of genetic testing in patients with breast Cancer: a review JO - JAMA Surg VL - 152 UR - https://doi.org/10.1001/jamasurg.2017.0552 DO - 10.1001/jamasurg.2017.0552 ID - Valencia2017 ER - TY - JOUR AU - Economopoulou, P. AU - Dimitriadis, G. AU - Psyrri, A. PY - 2015 DA - 2015// TI - Beyond BRCA: new hereditary breast cancer susceptibility genes JO - Cancer Treat Rev VL - 41 UR - https://doi.org/10.1016/j.ctrv.2014.10.008 DO - 10.1016/j.ctrv.2014.10.008 ID - Economopoulou2015 ER - TY - JOUR PY - 2004 DA - 2004// TI - CHEK2*1100delC and susceptibility to breast cancer: a collaborative analysis involving 10,860 breast cancer cases and 9,065 controls from 10 studies JO - Am J Hum Genet VL - 74 UR - https://doi.org/10.1086/421251 DO - 10.1086/421251 ID - ref3 ER - TY - JOUR AU - Zhang, B. AU - Beeghly-Fadiel, A. AU - Long, J. AU - Zheng, W. PY - 2011 DA - 2011// TI - Genetic variants associated with breast-cancer risk: comprehensive research synopsis, meta-analysis, and epidemiological evidence JO - Lancet Oncol VL - 12 UR - https://doi.org/10.1016/S1470-2045(11)70076-6 DO - 10.1016/S1470-2045(11)70076-6 ID - Zhang2011 ER - TY - JOUR AU - Easton, D. F. AU - Pharoah, P. D. AU - Antoniou, A. C. AU - Tischkowitz, M. AU - Tavtigian, S. V. AU - Nathanson, K. L. PY - 2015 DA - 2015// TI - Gene-panel sequencing and the prediction of breast-cancer risk JO - N Engl J Med VL - 372 UR - https://doi.org/10.1056/NEJMsr1501341 DO - 10.1056/NEJMsr1501341 ID - Easton2015 ER - TY - STD TI - Angeli D, Salvi S, Tedaldi G. Genetic predisposition to breast and ovarian cancers: how many and which genes to test? Int J Mol Sci. 2020;21(3):1128. https://doi.org/10.3390/ijms21031128. PMID: 32046255; PMCID: PMC7038038. ID - ref6 ER - TY - JOUR AU - Weischer, M. AU - Nordestgaard, B. G. AU - Pharoah, P. AU - Bolla, M. K. AU - Nevanlinna, H. AU - Veer, L. J. PY - 2012 DA - 2012// TI - CHEK2*1100delC heterozygosity in women with breast cancer associated with early death, breast cancer-specific death, and increased risk of a second breast cancer JO - J Clin Oncol VL - 30 UR - https://doi.org/10.1200/JCO.2012.42.7336 DO - 10.1200/JCO.2012.42.7336 ID - Weischer2012 ER - TY - JOUR AU - Thompson, D. AU - Seal, S. AU - Schutte, M. AU - McGuffog, L. AU - Barfoot, R. AU - Renwick, A. PY - 2006 DA - 2006// TI - A multicenter study of cancer incidence in CHEK2 1100delC mutation carriers JO - Cancer Epidemiol Biomark Prev VL - 15 UR - https://doi.org/10.1158/1055-9965.EPI-06-0687 DO - 10.1158/1055-9965.EPI-06-0687 ID - Thompson2006 ER - TY - JOUR AU - Weischer, M. AU - Bojesen, S. E. AU - Ellervik, C. AU - Tybjaerg-Hansen, A. AU - Nordestgaard, B. G. PY - 2008 DA - 2008// TI - CHEK2*1100delC genotyping for clinical assessment of breast cancer risk: meta-analyses of 26,000 patient cases and 27,000 controls JO - J Clin Oncol VL - 26 UR - https://doi.org/10.1200/JCO.2007.12.5922 DO - 10.1200/JCO.2007.12.5922 ID - Weischer2008 ER - TY - JOUR AU - Meijers-Heijboer, H. AU - Ouweland, A. AU - Klijn, J. AU - Wasielewski, M. AU - Snoo, A. AU - Oldenburg, R. PY - 2002 DA - 2002// TI - Low-penetrance susceptibility to breast cancer due to CHEK2(*)1100delC in noncarriers of BRCA1 or BRCA2 mutations JO - Nat Genet VL - 31 UR - https://doi.org/10.1038/ng879 DO - 10.1038/ng879 ID - Meijers-Heijboer2002 ER - TY - JOUR AU - Muranen, T. A. AU - Greco, D. AU - Blomqvist, C. AU - Aittomaki, K. AU - Khan, S. AU - Hogervorst, F. PY - 2017 DA - 2017// TI - Genetic modifiers of CHEK2*1100delC-associated breast cancer risk JO - Genet Med VL - 19 UR - https://doi.org/10.1038/gim.2016.147 DO - 10.1038/gim.2016.147 ID - Muranen2017 ER - TY - JOUR AU - Adank, M. A. AU - Hes, F. J. AU - Zelst-Stams, W. A. AU - Tol, M. P. AU - Seynaeve, C. AU - Oosterwijk, J. C. PY - 2015 DA - 2015// TI - CHEK2-mutation in Dutch breast cancer families: expanding genetic testing for breast cancer JO - Ned Tijdschr Geneeskd VL - 159 ID - Adank2015 ER - TY - JOUR AU - Adank, M. A. AU - Jonker, M. A. AU - Kluijt, I. AU - Mil, S. E. AU - Oldenburg, R. A. AU - Mooi, W. J. PY - 2011 DA - 2011// TI - CHEK2*1100delC homozygosity is associated with a high breast cancer risk in women JO - J Med Genet VL - 48 UR - https://doi.org/10.1136/jmedgenet-2011-100380 DO - 10.1136/jmedgenet-2011-100380 ID - Adank2011 ER - TY - BOOK PY - 2018 DA - 2018// TI - Breast Cancer Guideline (edition 2018) ID - ref14 ER - TY - JOUR AU - Douma, K. F. AU - Aaronson, N. K. AU - Vasen, H. F. AU - Gerritsma, M. A. AU - Gundy, C. M. AU - Janssen, E. P. PY - 2010 DA - 2010// TI - Psychological distress and use of psychosocial support in familial adenomatous polyposis JO - Psychooncology VL - 19 UR - https://doi.org/10.1002/pon.1570 DO - 10.1002/pon.1570 ID - Douma2010 ER - TY - JOUR AU - Wevers, M. R. AU - Ausems, M. G. AU - Verhoef, S. AU - Bleiker, E. M. AU - Hahn, D. E. AU - Brouwer, T. PY - 2016 DA - 2016// TI - Does rapid genetic counseling and testing in newly diagnosed breast cancer patients cause additional psychosocial distress? Results from a randomized clinical trial JO - Genet Med VL - 18 UR - https://doi.org/10.1038/gim.2015.50 DO - 10.1038/gim.2015.50 ID - Wevers2016 ER - TY - BOOK AU - Netherlands, S. PY - 2008 DA - 2008// TI - The Dutch Standard Classification of Education, SOI 2006 ID - Netherlands2008 ER - TY - BOOK PY - 2011 DA - 2011// TI - International Standard Classification of Education ID - ref18 ER - TY - BOOK PY - 2017 DA - 2017// TI - Breast cancer in the Netherlands ID - ref19 ER - TY - JOUR AU - Brohet, R. M. AU - Velthuizen, M. E. AU - Hogervorst, F. B. AU - Meijers-Heijboer, H. E. AU - Seynaeve, C. AU - Collee, M. J. PY - 2014 DA - 2014// TI - Breast and ovarian cancer risks in a large series of clinically ascertained families with a high proportion of BRCA1 and BRCA2 Dutch founder mutations JO - J Med Genet VL - 51 UR - https://doi.org/10.1136/jmedgenet-2013-101974 DO - 10.1136/jmedgenet-2013-101974 ID - Brohet2014 ER - TY - JOUR AU - Bock, G. H. AU - Schutte, M. AU - Krol-Warmerdam, E. M. AU - Seynaeve, C. AU - Blom, J. AU - Brekelmans, C. T. PY - 2004 DA - 2004// TI - Tumour characteristics and prognosis of breast cancer patients carrying the germline CHEK2*1100delC variant JO - J Med Genet VL - 41 UR - https://doi.org/10.1136/jmg.2004.019737 DO - 10.1136/jmg.2004.019737 ID - Bock2004 ER - TY - JOUR AU - Schmidt, M. K. AU - Hogervorst, F. AU - Hien, R. AU - Cornelissen, S. AU - Broeks, A. AU - Adank, M. A. PY - 2016 DA - 2016// TI - Age- and tumor subtype-specific breast Cancer risk estimates for CHEK2*1100delC carriers JO - J Clin Oncol VL - 34 UR - https://doi.org/10.1200/JCO.2016.66.5844 DO - 10.1200/JCO.2016.66.5844 ID - Schmidt2016 ER - TY - STD TI - Giesbertz NAA, van Harten WH, Bredenoord AL. A duty to recontact in genetics: context matters. Nat Rev Genet. 2019;20(7):371–2. https://doi.org/10.1038/s41576-019-0121-7. PMID: 30932026. ID - ref23 ER - TY - JOUR AU - Carrieri, D. AU - Lucassen, A. M. AU - Clarke, A. J. AU - Dheensa, S. AU - Doheny, S. AU - Turnpenny, P. D. PY - 2016 DA - 2016// TI - Recontact in clinical practice: a survey of clinical genetics services in the United Kingdom JO - Genet Med VL - 18 UR - https://doi.org/10.1038/gim.2015.194 DO - 10.1038/gim.2015.194 ID - Carrieri2016 ER - TY - JOUR AU - Sijmons, R. H. AU - Langen, I. M. AU - Sijmons, J. G. PY - 2011 DA - 2011// TI - A clinical perspective on ethical issues in genetic testing JO - Account Res VL - 18 UR - https://doi.org/10.1080/08989621.2011.575033 DO - 10.1080/08989621.2011.575033 ID - Sijmons2011 ER - TY - JOUR AU - Robson, M. E. AU - Storm, C. D. AU - Weitzel, J. AU - Wollins, D. S. AU - Offit, K. PY - 2010 DA - 2010// TI - American Society of Clinical Oncology policy statement update: genetic and genomic testing for cancer susceptibility JO - J Clin Oncol VL - 28 UR - https://doi.org/10.1200/JCO.2009.27.0660 DO - 10.1200/JCO.2009.27.0660 ID - Robson2010 ER - TY - JOUR AU - Hale, V. AU - Weischer, M. AU - Park, J. Y. PY - 2014 DA - 2014// TI - CHEK2 ( *) 1100delC mutation and risk of prostate Cancer JO - Prostate Cancer VL - 2014 UR - https://doi.org/10.1155/2014/294575 DO - 10.1155/2014/294575 ID - Hale2014 ER - TY - JOUR AU - Naslund-Koch, C. AU - Nordestgaard, B. G. AU - Bojesen, S. E. PY - 2016 DA - 2016// TI - Increased risk for other cancers in addition to breast Cancer for CHEK2*1100delC heterozygotes estimated from the Copenhagen general population study JO - J Clin Oncol VL - 34 UR - https://doi.org/10.1200/JCO.2015.63.3594 DO - 10.1200/JCO.2015.63.3594 ID - Naslund-Koch2016 ER - TY - JOUR AU - Siolek, M. AU - Cybulski, C. AU - Gasior-Perczak, D. AU - Kowalik, A. AU - Kozak-Klonowska, B. AU - Kowalska, A. PY - 2015 DA - 2015// TI - CHEK2 mutations and the risk of papillary thyroid cancer JO - Int J Cancer VL - 137 UR - https://doi.org/10.1002/ijc.29426 DO - 10.1002/ijc.29426 ID - Siolek2015 ER - TY - JOUR AU - Teodorczyk, U. AU - Cybulski, C. AU - Wokolorczyk, D. AU - Jakubowska, A. AU - Starzynska, T. AU - Lawniczak, M. PY - 2013 DA - 2013// TI - The risk of gastric cancer in carriers of CHEK2 mutations JO - Familial Cancer VL - 12 UR - https://doi.org/10.1007/s10689-012-9599-2 DO - 10.1007/s10689-012-9599-2 ID - Teodorczyk2013 ER - TY - STD TI - Hereditary Breast and Ovarian cancer study Netherlands https://www.hebon.nl/, sponsor: KWF project (2016–10758). UR - https://www.hebon.nl/ ID - ref31 ER - TY - JOUR AU - Romero Arenas, M. A. AU - Rich, T. A. AU - Hyde, S. M. AU - Busaidy, N. L. AU - Cote, G. J. AU - Hu, M. I. PY - 2018 DA - 2018// TI - Recontacting patients with updated genetic testing recommendations for medullary thyroid carcinoma and Pheochromocytoma or Paraganglioma JO - Ann Surg Oncol VL - 25 UR - https://doi.org/10.1245/s10434-018-6366-0 DO - 10.1245/s10434-018-6366-0 ID - Romero Arenas2018 ER - TY - STD TI - Chadwell SE, He H, Knapke S, Lewis J, Sisson R, Hopper J. Factors influencing clinical follow-up for individuals with a personal history of breast and/or ovarian Cancer and previous uninformative BRCA1 and BRCA2 testing. J Genet Couns. 2018;27(5):1210–9. https://doi.org/10.1007/s10897-018-0241-9. Epub 2018 Mar 17. PMID: 29550970. ID - ref33 ER - TY - JOUR AU - Otten, E. AU - Plantinga, M. AU - Birnie, E. AU - Verkerk, M. A. AU - Lucassen, A. M. AU - Ranchor, A. V. PY - 2015 DA - 2015// TI - Is there a duty to recontact in light of new genetic technologies? A systematic review of the literature JO - Genet Med VL - 17 UR - https://doi.org/10.1038/gim.2014.173 DO - 10.1038/gim.2014.173 ID - Otten2015 ER - TY - JOUR AU - Grindedal, E. M. AU - Jorgensen, K. AU - Olsson, P. AU - Gravdehaug, B. AU - Luras, H. AU - Schlichting, E. PY - 2020 DA - 2020// TI - Mainstreamed genetic testing of breast cancer patients in two hospitals in south eastern Norway JO - Familial Cancer VL - 19 UR - https://doi.org/10.1007/s10689-020-00160-x DO - 10.1007/s10689-020-00160-x ID - Grindedal2020 ER -